Abstract
Biocatalytic approaches have yielded efficient total syntheses of the major Amaryllidaceae alkaloids, all based on the key enzymatic dioxygenation of suitable aromatic precursors. This paper discusses the logic of general synthetic design for lycoricidine, narciclasine, pancratistatin, and 7-deoxypancratistatin. Experimental details are provided for the recently accomplished syntheses of narciclasine, ent-7-deoxypancratistatin, and 10b-epi-deoxypancratistatin via a new and selective opening of a cyclic sulfate over aziridines followed by aza-Payne rearrangement. The structural core of 7-deoxypancratistatin has also been degraded to a series of intermediates in which the amino inositol unit is cleaved and deoxygenated in a homologous fashion. These truncated derivatives and the compounds from the synthesis of the unnatural derivatives have been tested against six important human cancer cell lines in an effort to further develop the understanding of the mode of action for the most active congener in this group, pancratistatin. The results of the biological activity testing as well as experimental, spectral, and analytical data are provided in this manuscript for all relevant compounds.
Original language | English |
---|---|
Pages (from-to) | 8726-8743 |
Number of pages | 18 |
Journal | J. Org. Chem. |
Volume | 67 |
Issue number | 25 |
DOIs | |
Publication status | Published - 26 Jul 2002 |
Externally published | Yes |
Keywords
- Alkaloids
- Amaryllidaceae Alkaloids
- Angiosperms
- Animals
- Antineoplastic Agents, Phytogenic
- Catalysis
- Cyclization
- Drug Screening Assays, Antitumor
- Humans
- Isoquinolines
- Leukemia P388
- Mice
- Molecular Structure
- Nuclear Magnetic Resonance, Biomolecular
- Phenanthridines
- Plants, Medicinal
- Stereoisomerism
- Structure-Activity Relationship
- Tumor Cells, Cultured
- Biocatalysts
- Cells
- Derivatives
- Enzymes
- Synthesis (chemical)
- 10b epi deoxypancratistatin
- 7 deoxypancratistatin
- alkaloid
- aziridine derivative
- ent 7 deoxypancratistatin
- narciclasine
- unclassified drug
- 10b-epi-deoxypancratistatin
- 7-deoxypancratistatin
- Amaryllidaceae alkaloid
- antineoplastic agent
- isoquinoline derivative
- lycorine
- pancratistatin
- phenanthridine derivative
- article
- cancer cell culture
- drug activity
- drug mechanism
- drug structure
- drug synthesis
- angiosperm
- animal
- catalysis
- cell culture
- chemical structure
- chemistry
- cyclization
- drug effect
- drug screening
- human
- leukemia P 388
- medicinal plant
- mouse
- nuclear magnetic resonance
- stereoisomerism
- structure activity relation
- synthesis
- Organic compounds
Research fields
- Total Synthesis
- Alkaloids
- Amaryllidaceae alkaloids
IMC Research Focuses
- Materials science
ÖFOS 2012 - Austrian Fields of Study
- 104015 Organic chemistry